Novel molecular signatures are needed to improve the early and accurate diagnosis of autism spectrum disorder (ASD), and indicate physicians to provide timely intervention. This study aimed to identify a robust blood non-coding RNA (ncRNA) signature in diagnosing ASD. One hundred eighty six blood samples in the microarray dataset were randomly divided into the training set (n = 112) and validation set (n = 72). Then, the microarray probe expression profile was re-annotated into the expression profile of 4143 ncRNAs though probe sequence mapping. In the training set, least absolute shrinkage and selection operator (LASSO) penalized generalized linear model was adopted to identify the 20-ncRNA signature, and a diagnostic score was calculated for each sample according to the ncRNA expression levels and the model coefficients. The score demonstrated an excellent diagnostic ability for ASD in the training set (area under receiver operating characteristic curve [AUC] = 0.96), validation set (AUC = 0.97) and the overall (AUC = 0.96). Moreover, the blood samples of 23 ASD patients and 23 age- and gender-matched controls were collected as the external validation set, in which the signature also showed a good diagnostic ability for ASD (AUC = 0.96). In subgroup analysis, the signature was also robust when considering the potential confounders of sex, age, and disease subtypes. In comparison with a 55-gene signature deriving from the same dataset, the ncRNA signature showed an obviously better diagnostic ability (AUC: 0.96 vs 0.68, P < .001). In conclusion, this study identified a robust blood ncRNA signature in diagnosing ASD, which might help improve the diagnostic accuracy for ASD in clinical practice.

Articles you may be interested inEffect of intrinsic tensile stress on (001) orientation in L10 FePt thin films on glass substrates J. Appl. Phys. 111, 07A702 (2012); 10.1063/1.3670515 Microstructure and magnetic properties of rapidly annealed FePt (001) and FePt-MgO (001) films J. Appl. Phys. 97, 10N108 (2005); 10.1063/1.1850388 C -axis oriented L 1 0 phase FePt thin films by plasma-assisted diffusion (001)-oriented FePt films are deposited, by magnetron sputtering at 300 C, on LaAlO 3 (001), SrTiO 3 (001), and MgO (001) single crystal substrates. The tetragonal distortion, magnetic anisotropy, and the coercive force of the films vary with the substrate. The ordering process is very different with the substrate, which may affect the magnetic properties of the film. The magnetic coercivity decreases with increasing the ordering parameter and the tetragonal distortion, which may be ascribed to the lattice strain.